Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

908 Devices Inc (MASS)

908 Devices Inc (MASS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
2 Cathie Wood Stocks That Could Soar in 2024, According to Wall Street

Wall Street is uber-bullish on these two Ark Invest holdings.

MASS : 3.47 (+4.52%)
BEAM : 24.72 (+7.34%)
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street

These cutting-edge biotech stocks could deliver life-changing gains for early shareholders.

PFE : 29.16 (-0.61%)
BEAM : 24.72 (+7.34%)
CMPS : 6.02 (-0.50%)
MASS : 3.47 (+4.52%)
908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer

908 Devices Inc ., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release of a data analysis tool that provides a quick and...

MASS : 3.47 (+4.52%)
Resilience Demonstrates Lower Cost of Perfusion Bioreactor Process Using 908 Devices’ REBEL At-line Analyzer

908 Devices Inc ., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced that National Resilience, Inc. (Resilience), a technology-focused...

MASS : 3.47 (+4.52%)
908 Devices to Report First Quarter Financial Results on May 9, 2023

908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2023 before market...

MASS : 3.47 (+4.52%)
908 Devices Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Revenue Outlook

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter and full year ended December...

MASS : 3.47 (+4.52%)
908 Devices to Participate in the Cowen 43rd Annual Healthcare Conference

908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will participate in the upcoming Cowen 43 rd Annual Healthcare Conference...

MASS : 3.47 (+4.52%)
908 Devices to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023

908 Devices Inc., (Nasdaq: MASS) a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the fourth quarter and full year 2022...

MASS : 3.47 (+4.52%)
908 Devices Unveils New Glucose and Lactate On-Line Device for Bioprocess Monitoring and Control

908 Devices Inc. (Nasdaq: MASS), a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced the launch of MAVEN , a device for on-line monitoring and control of...

MASS : 3.47 (+4.52%)
MX908 Device Enables Correctional Facility Personnel to Quickly Identify Illegal Drugs in Incoming Mail

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positive impact of the MX908 handheld...

MASS : 3.47 (+4.52%)

Barchart Exclusives

Microsoft Stock Has Underperformed in 2024, But Can It Catch Up in Q4?
Microsoft stock is underperforming the markets, as well as its Big Tech peers, in 2024. Can MSFT stock play catch-up in the final quarter of the year? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar